Arthneeti

Vital Chemtech Q2 FY27 Share Price & Earnings Call Analysis

₹50.36+2.78% today
Market cap
₹121 Cr
P/E
46.03
ROE
1.01%
PEG
-0.91
Price to sales
0.96
Debt to equity
0.62
52W high / low
₹66.2 / ₹35.4
EBITDA margin
7.96%
Net profit margin
0.80%
Promoter holding
73.43%
Sales (last year)
₹126 Cr

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Vital Chemtech rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹234 Cr3.0
240%+Flat₹3,888 Cr48.5
340%+Flat₹3,514 Cr4.3
440%+Flat₹180 Cr11.9
540%+Flat₹138 Cr15.1
620–40%Up 2%+₹1.70L Cr85.4

Sign up free to see every company in the sector ranking and track Vital Chemtech.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Vital Chemtech

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Vital Chemtech

Shareholding breakup across reporting periods.

Nov 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Jun 2026Sep 2026
Promoters +73.28%73.43%73.43%73.43%73.43%73.43%73.43%73.43%73.43%73.43%
FIIs +6.53%3.62%0.78%0.56%0.16%1.78%1.78%1.62%1.62%1.62%
DIIs +4.12%1.81%0.96%0.33%0.25%0.25%0.25%0.25%0.25%0.25%
Public +16.07%21.14%24.83%25.68%26.16%24.54%24.54%24.70%24.70%24.70%
No. of Shareholders2,2841,8792,2762,3202,4322,1422,0922,0232,0982,130

Financials of Vital Chemtech

Quarterly Results

Quarter-by-quarter operating performance

Mar 2025Jun 2025Dec 2025Mar 2026Jun 2026
Sales +35.0733.8026.7535.1451.19
YoY Sales growth+0.20%+51.45%
Expenses +32.2231.2725.4031.1645.10
Operating Profit2.852.531.353.986.09
OPM %8.13%7.49%5.05%11.33%11.90%
Other Income +0.620.280.190.240.13
Interest0.500.471.001.221.00
Depreciation1.271.111.682.041.79
Profit before tax1.701.23-1.140.963.43
Tax %31.18%21.14%16.67%12.50%24.78%
Net Profit +1.170.98-1.330.842.59
EPS in Rs0.490.41-0.560.351.08

Financials of Vital Chemtech

Profit & Loss

Annual income statement trend

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +5811798134126
Sales growth+103%-16%+36%-6%
Expenses +4610298123116
Operating Profit121501110
OPM %20%13%0.2%8%8%
Other Income +00331
Interest01123
Depreciation12356
Profit before tax1111-062
Tax %26%30%269%34%51%
Net Profit +88-141
EPS in Rs4.703.36-0.541.660.43
Dividend Payout %0%15%-92%0%0%

Financials of Vital Chemtech

Balance Sheet

Capital structure and asset base

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital724242424
Reserves866607675
Borrowings +3629266662
Other Liabilities +3019274158
Total Liabilities81138137207219
Fixed Assets +1725436858
CWIP0001543
Investments315351313
Other Assets +619860111105
Total Assets81138137207219

Financials of Vital Chemtech

Cash Flows

Operating, investing and financing cash movement

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-13-81465
Cash from Investing Activity +1-26-35-39-5
Cash from Financing Activity +1858-9331
Net Cash Flow624-3000
Free Cash Flow-22-18-7-40-19
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit-91%-36%7,410%75%59%

Financials of Vital Chemtech

Ratios

Working capital efficiency and return ratios

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days264120146106115
Inventory Days87576147120
Days Payable26565111115185
Cash Conversion Cycle87112963949
Working Capital Days59116785541
ROCE %15%0%6%3%

Continue your research

What Vital Chemtech's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • J.G.Chemicals (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd

  • Lords Chloro (Q2 FY27)

    115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

Compare:vs Solar Industriesvs Pidilite Industriesvs SRF